BioPharma Credit PLC
LSE: BPCR.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Financial Services
- Industry
- Asset Management
- CEO
- Pedro Gonzalez de Cosio
- Headquarters
- Exeter, United Kingdom
- IPO year
- 2017
- Market cap
- $1.1B
- Website
- https://www.bpcruk.com
Loading BPCR…
Loading profile data…Frequently asked questions about BPCR
What does BioPharma Credit PLC (BPCR.L) do?
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Where does BPCR.L trade?
BioPharma Credit PLC (BPCR.L) trades on the London Stock Exchange.
What sector is BPCR.L in?
BioPharma Credit PLC (BPCR.L) operates in the Financial Services sector, specifically in the Asset Management industry.
Who is the CEO of BioPharma Credit PLC?
Pedro Gonzalez de Cosio is the chief executive officer of BioPharma Credit PLC (BPCR.L).
Where is BioPharma Credit PLC headquartered?
BioPharma Credit PLC is headquartered in United Kingdom.
Does BPCR.L pay a dividend?
Yes — BioPharma Credit PLC (BPCR.L) paid a trailing twelve-month dividend of USD 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BPCR.L go public?
BioPharma Credit PLC (BPCR.L) completed its initial public offering in 2017.